Global Brachytherapy Treatment Planning Systems Market: Current Analysis and Forecast (2022-2028)

Global Brachytherapy Treatment Planning Systems Market: Current Analysis and Forecast (2022-2028)

Brachytherapy is a type of radiotherapy where a radioactive source is placed inside or close to the area that requires treatment. This allows for a high dose of radiation to be delivered to a specific area while minimizing exposure to surrounding healthy tissue. Brachytherapy allows a higher dose of radiation in a smaller area than might be possible with external radiation treatment. It uses a radiation source that’s usually sealed in a small holder called an implant. The increasing prevalence of cancer along with the increasing adoption of early diagnostic procedures attributes to the market growth of the brachytherapy treatment planning systems market. For instance, according to the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Furthermore, the increasing acceptance of radiation therapy in the treatment of cancer diseases is also a supplementing factor responsible for the growth of the market.

The Brachytherapy Treatment Planning Systems Market is expected to grow at a steady rate of around 8% owing to the frequent launches of brachytherapy services. For instance, in June 2022, RaySearch Laboratories AB (publ) announces the launch of RayStation®* 12A, the latest version of the company’s advanced treatment planning system. Version 12A includes innovative new features in addition to several general enhancements.

• Based on the component, the market has been categorized into auto-contouring software, multi-modality software, PET/CT deformable software, and DICOM-RT software. Among them, the auto-contouring software segment holds a dominant share of the market in 2021. The increasing number of out-patients increases the pressure on the radiotherapy staff which increases the risks of ineffective and decreased accuracy during the procedures attributed to the high demand for auto-contouring software.
• Based on the techniques, the market has been categorized into 3D image reconstruction, in-room imaging, and image registration using a graphics processor unit. Among them, the 3D image reconstruction in brachytherapy involves the creation of a 3D model of a patient's anatomy from medical imaging data to guide the placement of radioactive sources during treatment. This allows for more precise delivery of radiation therapy, reducing the exposure of healthy tissue and improving treatment outcomes. The usage of 3D image reconstruction techniques in dosage distribution planning and the increasing demand for accurate & precise oncology treatment practices attributes to the fast growth of the segment.
• For a better understanding of the market adoption of the brachytherapy treatment planning systems industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated hold a dominant market share in 2021. This is mainly due to the presence of leading companies offering a range of brachytherapy treatment planning systems, including software solutions and hardware systems, to meet the diverse needs of healthcare providers and patients. The market is expected to continue growing, driven by factors such as an aging population, increasing incidence of cancer, and continuous advancements in technology.
• Some of the major players operating in the market are Elekta; Varian Medical Systems, Inc.; MIM Software Inc.; RaySearch Laboratories; Prowess Inc.; Concure Oncology; BEBIG Medical GmbH; Sensus Healthcare; Isoray Inc.; and IsoAid.